Picard Medical IncPMI
Price$4.32Intrinsic value$1.2372% below price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
FY EPS (est.)
-$8.50next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Total Revenue Annually4.9M
First Quarter Revenue Quarterly1.2M
First Quarter Gross Margin Quarterly24.0%
SynCardia Total Artificial Heart Implants Annually2.1K
Watch Items
  • NYSE American Stockholders' Equity Compliance PlanTrigger: Submission deadline of June 7, 2026, to address stockholders' equity deficiencyAction: Submit and execute a compliance plan to maintain the NYSE American listing
  • Going-Concern Qualification ResolutionTrigger: Presence of going-concern qualification in 2025 financial statementsAction: Continue debt reduction, gross margin improvement, and capital structure initiatives to stabilize financial position
  • Emperor Total Artificial Heart DevelopmentTrigger: Targeting clinical study launch by 2028Action: Complete non-clinical testing, regulatory reviews, and advance preclinical animal studies
Sign in / Sign up to read more

Research as of 20 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.